Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Compare the pros and cons of zero based budgeting and traditional budgeting, featuring practical considerations for different financial situations.
28,655 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Investors are watching Bionano Genomics as the company enters 2026 with evolving demand for optical genome mapping. T...
A sweeping update from Fannie Mae and Freddie Mac is redefining how condos are financed, insured, and funded. The pol...
When SK Hynix opened its largest-ever share sale, demand overwhelmed the supply, and investors wanted billion more. T...
A sudden dividend cut or pause can shake confidence and cash flow. This guide explains what to do when there goes div...
Feb 2026 marks a turning point for buyers, with discounts piling up across the market. This guide breaks down where s...
Jamie Dimon’s long tenure has anchored JPMORGAN CHASE through crises and growth. If he leaves, the bank faces a stage...
Taylor Morrison introduces a formal integration playbook designed to merge two distinct brands without sacrificing lo...
Cerebras Systems stock crashed after its latest earnings report, leaving investors asking what happened and what come...
Policy clarity clears the path for road ahead build-to-rent projects, lifting investor confidence. Still, the pace of...
Former President Trump claimed AI data centers should pay for their own electricity in a recent address, triggering a...
Conagra Brands is pouring $220 million into a key manufacturing upgrade, signaling confidence in demand. But does tha...